Meet MCMi -- Faces Behind the Initiative

"The staff working on this broad agency effort are exceptionally qualified and extremely committed. This initiative is a very complex, long-term effort that calls for collaboration, continuing support, and the ability to do things a little differently."
   -- Luciana Borio, M.D., Assistant Commissioner for Counterterrorism Policy and Director, OCET

FDA's Medical Countermeasures initiative (MCMi) is an agency-wide effort to facilitate the availability of the drugs, vaccines, detection devices, and other equipment that will be needed to counter a chemical, biological, radioactive, or nuclear agent or an emerging infectious disease threat.  Working on MCMi are scientific staff from FDA's three medical product centers and the Office of Counterterrorism and Emerging Threats (OCET), which provides additional staff and resources to support their work.

We invite you meet some of the professionally diverse FDA staff involved in the MCMi.  

• Luciana Borio, Director
  Office of Counterterrorism and Emerging Threats
  Office of the Chief Scientist
  
   
• William Dickerson, Radiation Oncologist, Medical Reviewer
  Division of Medical Imaging Products
  Center for Drug Evaluation and Research
  
   
• Sally Hojvat, Director of the Division of Microbiology Devices
  Office of In-vitro Diagnostic (IVD) Device Evaluation and Safety
  Center for Devices and Radiological Health

• Suzanne Schwartz, Director of Emergency Preparedness/Operations
   and Medical Countermeasures
  Office of the Center Director
  Center for Devices and Radiological Health